Related Experiment Video
Updated: May 23, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
GMP implementation in China: A double-edged sword for the pharmaceutical industry
1Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
Abstract:
China's Good Manufacturing Practice (GMP) standards that mainly parallel WHO standards were made compulsory in 2004. However, GMP implementation had both positive as well as negative impacts on the pharmaceutical industry, with negatives including pharmaceutical companies suffering economic hardships, poor execution of GMP standards, and sequent health scares. This report briefly describes the problems with GMP implementation in China.
Related Concept Videos
Drug Regulation
FDA Approved Drugs: Changes to Approved Drugs
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Production of Pharmaceuticals
Drug Control Governance: Regulatory Bodies and Their Impact
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

